Mr. Speaker, the hon. member knows very well that we have a process here in Canada that is the envy of the rest of the world. The assessment is made based on science and the safety of any genetically modified product to humans, animals and to the environment. Even with that, it does not mean that the product goes to market. If it passes, the opportunity is there. There have been a number of cases. For example, a number of years ago there was a genetically modified flax product that did pass and the industry decided not to take it to market.
In the House of Commons on May 29th, 2003. See this statement in context.